Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2002
10/16/2002CN1374080A Prepn and use of composition with cracked disulfide bond
10/16/2002CN1374079A Antiviral drug containing silverweed cinquefoil essence and its prepn
10/16/2002CN1092663C Novel cephalosporin derivatives and processes for producing the same
10/16/2002CN1092647C New antiviral substituted pyrimidinedione homocarbocylic nucleoside derivatives and methods for preparation thereof and composition containing the same as active ingredients
10/16/2002CN1092640C Imides as PDE III, PDE IV and TNF inhibitors
10/16/2002CN1092524C Chinese herbal medicine for radically treating rabies
10/15/2002US6465686 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/15/2002US6465621 Polypeptides and polynucleotides of the gtp-binding protein family
10/15/2002US6465518 2-amino-5-fluoro-6-(1-iminoethylamino)-hept-4-enoic acid, for example; treating or preventing various causes of inflammation
10/15/2002US6465511 Treatment of septic shock
10/15/2002US6465487 Inhibition of membrane-associated viral replication
10/15/2002US6465476 Immuno-modulator exhibiting antimicrobial and anti-mycrobacterial activities, method for producing the same and pharmaceutical preparation
10/15/2002US6465468 Hydroxamic and carboxylic acid derivatives
10/15/2002US6465438 Nucleic acid vaccination for parvoviral infections
10/15/2002US6465437 Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
10/15/2002US6465433 Boronic ester and acid compounds, synthesis and uses
10/15/2002US6465172 HIV immunogenic complexes comprising GP120 covalently bound to CD4 or concanavalin A
10/15/2002US6465003 Drug delivery
10/15/2002US6464997 Mutualistic combination of said spirulina platensis powder and fungus selected from the phylum basideomnycota; pesticidal agent
10/15/2002US6464987 Pharmaceutical compositions capable of being gelled
10/15/2002US6464985 Ospc dra fragment fusion peptide isolated from borrelia burgdorferi
10/15/2002US6464984 Avian polynucleotide vaccine formula
10/15/2002US6464976 Selective anti-viral immuno-depletion (savid) immunoaffinity chromatographic material; viral coat protein of an adenovirus linked to a chromatographic support
10/15/2002US6464971 Anionic or cationic dendrimer antimicrobial or autiprotozoan compositions
10/15/2002CA2091766C Enhancement of glutathione levels with glutamine
10/15/2002CA2067274C Solvates of dirithromycin and a process for isolating form ii dirithromycin
10/15/2002CA2063521C Tacky, hydrophilic gel dressings and products therefrom
10/10/2002WO2002079517A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
10/10/2002WO2002079475A2 Streptococcus pyogenes antigens and corresponding dna fragments
10/10/2002WO2002079464A2 Viral vectors
10/10/2002WO2002079448A2 G-protein coupled receptors
10/10/2002WO2002079441A2 Secreted proteins
10/10/2002WO2002079417A2 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/10/2002WO2002079408A2 Short bioactive peptides and methods for their use
10/10/2002WO2002079404A2 Cytoskeleton-associated proteins
10/10/2002WO2002079397A2 Virus derived antimicrobial peptides
10/10/2002WO2002079299A1 Agent for the prevention and treatment of sexually transmitted diseases-i
10/10/2002WO2002079298A1 Agents for the prevention and treatment of sexually transmitted diseases -ii
10/10/2002WO2002079249A2 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
10/10/2002WO2002079247A2 Intimins in the prevention or treatment of infections:ii
10/10/2002WO2002079243A2 Gonococcal proteins and nucleic acids
10/10/2002WO2002079240A2 Intimins for the prevention or treatment of infections: i
10/10/2002WO2002079194A1 Ccr5 antagonists useful for treating aids
10/10/2002WO2002079191A1 Viologen linked acridine based molecule and process for the preparation thereof
10/10/2002WO2002079188A1 Pyrrolidine sulfonamides
10/10/2002WO2002079186A2 Aminopiperidine derivatives as modulators of chemokine receptor activity
10/10/2002WO2002079183A1 Halogenated rhodamine derivatives and applications thereof
10/10/2002WO2002079164A1 Quinoline derivatives and their use as antibiotics
10/10/2002WO2002079157A1 Aryl oxime-piperazines useful as ccr5 antagonists
10/10/2002WO2002079156A1 Novel piperidine derivatives as modulators of chemokine receptor
10/10/2002WO2002079154A1 Substituted carbazoles as inhibitors of spla2
10/10/2002WO2002079147A2 Inhibitors of prenyl-protein transferase
10/10/2002WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002WO2002078733A1 Monocyte-specific particulate delivery vehicle
10/10/2002WO2002078730A2 Use of neublastin polypeptides for treating neuropathic pain
10/10/2002WO2002078720A2 Antibiotics from bacteria isolated from amphibian skin
10/10/2002WO2002078718A2 Compositions, methods and apparatuses for singlet oxygen delivery
10/10/2002WO2002078717A2 Compositions and methods for reducing rna virus pathogenicity
10/10/2002WO2002078714A1 Formulations which are resistant to gastric juice and are used to apply anti-infective compounds inhibiting the 2-c-methylerythrose-4 metabolic pathway, and the salts and esters of the same
10/10/2002WO2002078709A2 Use of pyrido`2,3-d pyrimidin derivatives for the treatment of human cytomegalovirus infections
10/10/2002WO2002078708A1 Hiv inhibiting pyrazinone derivatives
10/10/2002WO2002078705A1 Hsp inductor
10/10/2002WO2002078701A1 Use of pyrazolopyridines as therapeutic compounds
10/10/2002WO2002078700A1 Pyralopyridines, process for their preparation and use as therapteutic compounds
10/10/2002WO2002078698A2 Polarisation of dendritic cells (treatment of infections, cancer and autoimmune diseases) using histamine
10/10/2002WO2002078682A2 Estrogen replacement therapy
10/10/2002WO2002078648A2 Topical composition comprising an antifungal
10/10/2002WO2002078634A2 Methods for using kdop and kdop synthase inhibitors for the treatment of bacterial infection
10/10/2002WO2002078631A2 Improved conditionally replicating vectors for inhibiting viral infections
10/10/2002WO2002078628A2 Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazapines as hiv reverse transcriptase inhibitors
10/10/2002WO2002078627A2 N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
10/10/2002WO2002078624A2 Aerosol administration of interleukin-2 liposomes
10/10/2002WO2002078599A2 CD8α + LYMPHOID DENDRITIC CELL DIFFERENTIATED FROM HUMAN HEMATOPOIETIC STEM CELL AND A METHOD FOR DIFFERENTIATION
10/10/2002WO2002078516A2 Compositions and methods for the therapy and diagnosis of cancer
10/10/2002WO2002057287A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
10/10/2002WO2002051413A3 Macrocyclic anti-viral compounds
10/10/2002WO2002024706A3 Water soluble rapamycin esters
10/10/2002WO2002010343A3 Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
10/10/2002WO2002004612A3 Drug metabolizing enzymes
10/10/2002WO2001098353A3 Secreted proteins
10/10/2002WO2001095929A3 Interferon for treatment of multiple sclerosis
10/10/2002WO2001078787A3 Lipopolysaccharide-conjugate vaccine for sepsis treatment
10/10/2002WO2001077174A3 Human transporters and ion channels
10/10/2002WO2001074382A9 Method of treatment using ligand-immunogen conjugates
10/10/2002WO2001072728A9 Novel piperazine derivatives
10/10/2002US20020147332 Novel nucleoside and oligonucleotide analogues
10/10/2002US20020147238 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using R(-)-ketoprofen
10/10/2002US20020147235 Storage stable microbiocides
10/10/2002US20020147224 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/10/2002US20020147210 Methods for delaying recurrence of herpes virus symptoms
10/10/2002US20020147198 Substituted arylamine derivatives and methods of use
10/10/2002US20020147192 Viricides; antiinflammatory agents; antiallergens; antiarthritic agents
10/10/2002US20020147188 Protease inhibitors
10/10/2002US20020147181 Viricides
10/10/2002US20020147180 Stable amorphous amifostine compositions and methods for the preparation of same
10/10/2002US20020147160 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
10/10/2002US20020147156 Cellular uptake of bioactive agents
10/10/2002US20020147144 Prevention, therapy autoimmune diseases; anticholesterol agents
10/10/2002US20020147139 Viricides
10/10/2002US20020147130 Treatment of hiv
1 ... 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 ... 1798